Jose Luis Labandeira-Garcia

Full Professor

Universidade de Santiago de Compostela

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jose Luis Labandeira-Garcia is a Full Professor at Universidade de Santiago de Compostela, Spain. His research focuses on neuroinflammation, oxidative stress, and the role of the renin-angiotensin system in neurodegenerative diseases, evidenced by his recent articles on biomarkers in Alzheimer's disease and Parkinson’s disease. He also explores the implications of small extracellular vesicles in atrial fibrillation and pediatric thyroid neoplasms.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

Maria Campos-Magdaleno

Professor

Universidade de Santiago de Compostela

SPAIN

Jose Luis Labandeira-Garcia

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Plasma and neurostructural biomarkers in the clinical-biological characterization of early stages of the Alzheimer's disease continuum: findings from the Compostela Aging Study

Renin–Angiotensin System Autoantibody Network in Parkinson’s Disease Patients

Plasma small extracellular vesicles: Markers and mediators of atrial scar, in patients with atrial fibrillation.

DICER1-Related Pediatric Thyroid Neoplasm with Follicular and Morular Growth: A Tumor that Did Not Read the Textbook.

Delivery of monoclonal antibodies to the brain: the impact of nanocarrier structure.

Involvement of Neuroinflammation and Oxidative Stress in L-DOPA-Induced Dyskinesia in Parkinson’s Disease: Role of Renin–Angiotensin System and ROCK Pathway

Defective Olfactomedin-2 connects adipocyte dysfunction to obesity.

Renin-angiotensin system as an emerging target to modulate adult neurogenesis in health and disease.

JNK1 in SF1 neurons regulates the central action of thyroid hormones on hepatic lipid metabolism.

Serum angiotensin type-1 receptor autoantibodies and neurofilament light chain as markers of neuroaxonal damage in post-COVID patients.

Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia

Combined cell-based therapy strategies for the treatment of Parkinson's disease: focus on mesenchymal stromal cells.

The cannabinoid CB<sub>1</sub> receptor interacts with the angiotensin AT<sub>2</sub> receptor. Overexpression of AT<sub>2</sub>-CB<sub>1</sub> receptor heteromers in the striatum of 6-hydroxydopamine hemilesioned rats.

Microglial angiotensin type 2 receptors mediate sex‐specific expression of inflammatory cytokines independently of circulating estrogen

AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability.

Small extracellular vesicle targeting of hypothalamic AMPKα1 promotes weight loss in leptin receptor deficient mice.

Inflammatory Role of Milk Fat Globule-Epidermal Growth Factor VIII in Age-Associated Arterial Remodeling.

Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene.

Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease.

Angiotensin System Autoantibodies Correlate With Routine Prognostic Indicators for COVID-19 Severity.

Collaborators (16)

Maria Campos-Magdaleno

Ramaroson Andriantsitohaina

Jorge Rodríguez Castro

Rita Valenzuela Limiñana

Juan A. Parga

Ana Muñoz

Ana Isabel Rodriguez Perez

María García Garrote

Aina Lluch Balaña

M Carmen Martinez

Maria Jose Alonso

Santiago Galdo-Alvarez

Montserrat Zurrón

Johannes Graumann

Jannette Rodriguez-Pallares

Miguel Ángel Rivas-Fernández

Make your next move.